CSS LLC’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

CSS LLC’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,400	Closed	-$6.88K	–	1008
2023 Q3	$6.88K	Buy	+5,400	New	+$4.72K	﹤0.01%	777
2020 Q3	–	Sell	-10,000	Closed	-$34K	–	883
2020 Q2	$34K	Buy	+10,000	New	+$47.3K	﹤0.01%	591

CSS LLC's ZYNE Position: Q4 2023 in Review

CSS LLC sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 476,831 shares — an estimated $608K sold.

CSS LLC first reported a position in ZYNE in Q2 2020 and held it in 2 quarters. The position peaked at $608K in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

CSS LLC reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
CSS LLC sold 476,831 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $608K.
CSS LLC first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2020 and held it in 2 quarters.
CSS LLC's Zynerba Pharmaceuticals, Inc position peaked at $608K in Q3 2023.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on CSS LLC's 13F filing for Q4 2023, filed 14 Feb 2024.